• 

  Dr Reddy's posts Q4 profit of Rs 554 crore, revenues at Rs 4,728 crore

  Business | May 14, 2021 14:27 IST

  Net sales however rose to Rs 4,608 crore in the quarter under review as compared with Rs 4,336.1 crore in the fourth quarter of 2019-20, Dr Reddy's Laboratories said in a regulatory filing.

• 

  Dr Reddy's isolates data centres services following cyber-attack

  Business | October 23, 2020 12:53 IST

  Dr Reddy’s Laboratories recently received regulatory approvals to conduct human trials of a Covid-19 vaccine candidate developed by a Russian research institute.

• 

  Dr Reddy's Lab shares jump over 4% after Russia COVID-19 vaccine Sputnik V agreement

  Business | September 16, 2020 19:48 IST

  Shares of Dr Reddy's Laboratories gained over 4 per cent on Wednesday after the company and Russia's sovereign wealth fund RDIF agreed to supply 100 million (10 crore) doses of Sputnik V COVID-19 vaccine to the drug maker upon getting regulatory approval in India.

• 

  Dr. Reddy's partners with Russia for clinical trial of Sputnik V in India

  India | September 16, 2020 15:24 IST

  Dr. Reddy's Laboratories has signed a deal with the Russian Direct Investment Fund to conduct a clinical trial and distribution of coronavirus vaccine Sputnik V in India. According to the agreement, Russia's sovereign wealth fund will supply 100 million doses of the COVID-19 vaccine to India. 

• 

  Dr Reddy's Laboratories launches COVID-19 treatment drug 'Favipiravir' in India

  India | August 19, 2020 13:48 IST

  Dr Reddy's Laboratories has announced the launch of Avigan (Favipiravir) tablets, used for COVID-19 treatment, in India. The drug major said that Avigan has been approved by the Drugs Controller General of India (DCGI) for the treatment of patients with mild to moderate COVID-19.

• 

  Dr Reddy's to acquire Wockhardt select generics for Rs 1850 crore

  Business | February 12, 2020 17:26 IST

  ​Dr Reddy's Laboratories Ltd entered into a definitive agreement with Wockhardt Ltd to acquire select divisions of itsbranded generics business in India and a few other international territories, including Sri Lanka and Maldives for Rs 1850 crores, the drug maker said on Wednesday. 

• 

  Dr Reddy's launches capsules to remove copper from blood

  Business | February 07, 2020 14:07 IST

  Dr Reddy's Laboratories Ltd on Friday announced the launch of Trientine Hydrochloride capsules in the US market. Trientine works by removing copper from the blood. It is used to treat Wilson's disease, a genetic metabolic defect that causes excess copper to build up in the body.

• 

  Dr Reddy's Laboratories to expand capacity of manufacturing units in Telangana

  February 04, 2015 17:39 IST

  Hyderabad: Drug maker Dr Reddy's Laboratories is set to expand the capacity of three of its bulk drugs and intermediates manufacturing plants located in Telangana, with a combined investment of Rs 82 crore.  The company

• 

  Dr. Reddy's acquires nicotine therapy patch Habitrol

  December 19, 2014 17:08 IST

  New Delhi: Dr Reddy's Laboratories (DRL) Friday said it has completed the acquisition of the brand Habitrol, an over-the-counter nicotine therapy transdermal patch from Novartis Consumer Health.The patch is used to decrease withdrawal symptoms triggered

• 

  LIC sells Dr Reddy's shares for Rs 875 cr; cuts stake to 6.31%

  January 22, 2013 17:35 IST

   New Delhi, Jan 22: Drug firm Dr Reddy's Laboratories on Tuesday said state-run Life Insurance Corporation (LIC) has cut its stake in the company to 6.31 per cent by selling shares worth Rs 875.29 crore